Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Graeber

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Nature|May 20, 2011
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Nature Communications|November 21, 2024
Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in gliomaElizabeth G Fernandez, Wilson X Mai, Kai Song, et al.
Cancer Research|June 8, 2011
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersNicolaos Palaskas, Steven M Larson, Nikolaus Schultz, et al.
Science (New York, N.Y.)|March 2, 2013
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responsesRosane M B Teles, Thomas G Graeber, Stephan R Krutzik, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
Cell|August 9, 2016
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate CancerJustin M Drake, Evan O Paull, Nicholas A Graham, et al.
JCI Insight|December 7, 2020
Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicityShen Li, Feiyang Ma, Tomohiro Yokota, et al.
Nature|November 25, 2011
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, et al.
Cell Reports|February 16, 2016
MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4Candice Sun Hong, Nicholas A Graham, Wen Gu, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Nature|May 20, 2011
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Nature Communications|November 21, 2024
Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in gliomaElizabeth G Fernandez, Wilson X Mai, Kai Song, et al.
Cancer Research|June 8, 2011
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersNicolaos Palaskas, Steven M Larson, Nikolaus Schultz, et al.
Science (New York, N.Y.)|March 2, 2013
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responsesRosane M B Teles, Thomas G Graeber, Stephan R Krutzik, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
Cell|August 9, 2016
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate CancerJustin M Drake, Evan O Paull, Nicholas A Graham, et al.
JCI Insight|December 7, 2020
Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicityShen Li, Feiyang Ma, Tomohiro Yokota, et al.
Nature|November 25, 2011
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, et al.
Cell Reports|February 16, 2016
MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4Candice Sun Hong, Nicholas A Graham, Wen Gu, et al.
Pageof 14